These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 7814483

  • 21. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W, Sanabani SS, Jamal LF, Sabino EC.
    Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
    [Abstract] [Full Text] [Related]

  • 22. Molecular characterization of human T-cell lymphotropic virus type 2 (HTLV-II) from people living in urban areas of Sao Paulo city: evidence of multiple subtypes circulation.
    Novoa P, Penalva de Oliveira AC, Posada Vergara MP, da Silva Duarte AJ, Casseb J.
    J Med Virol; 2007 Feb; 79(2):182-7. PubMed ID: 17177305
    [Abstract] [Full Text] [Related]

  • 23. Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens.
    Vallejo A, García-Sáiz A.
    J Virol Methods; 1995 Jan; 51(1):9-17. PubMed ID: 7730441
    [Abstract] [Full Text] [Related]

  • 24. Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified western blot containing recombinant envelope glycoproteins.
    Brodine SK, Kaime EM, Roberts C, Turnicky RP, Lal RB.
    Transfusion; 1993 Jan; 33(11):925-9. PubMed ID: 7903127
    [Abstract] [Full Text] [Related]

  • 25. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.
    Heneine W, Khabbaz RF, Lal RB, Kaplan JE.
    J Clin Microbiol; 1992 Jun; 30(6):1605-7. PubMed ID: 1624585
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II.
    Liu H, Shah M, Stramer SL, Chen W, Weiblen BJ, Murphy EL.
    Transfusion; 1999 Jun; 39(11-12):1185-93. PubMed ID: 10604244
    [Abstract] [Full Text] [Related]

  • 28. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM, Remesar M, del Pozo A, Sen L.
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [Abstract] [Full Text] [Related]

  • 29. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB.
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.
    Ehrlich GD, Glaser JB, LaVigne K, Quan D, Mildvan D, Sninsky JJ, Kwok S, Papsidero L, Poiesz BJ.
    Blood; 1989 Oct; 74(5):1658-64. PubMed ID: 2790192
    [Abstract] [Full Text] [Related]

  • 31. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users.
    Aboulafia DM, Feigal E, Vranzian K, Bennett C, Blattner W, Moss A, Slamon D.
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1043-50. PubMed ID: 7904169
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.
    Malm K, Kjerstadius T, Andersson S.
    J Med Virol; 2010 Sep; 82(9):1606-11. PubMed ID: 20648617
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group.
    Henrard DR, Soriano V, Robertson E, Gutierrez M, Stephens J, Dronda F, Miles F, Pujol E, Buytendorp M, Castro A.
    J Clin Microbiol; 1995 Jul; 33(7):1735-8. PubMed ID: 7665638
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J, Baillou A, Barin F, Verdier M, Janvier B, Denis F.
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [Abstract] [Full Text] [Related]

  • 36. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH, McAlpine L, Mortimer PP.
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [Abstract] [Full Text] [Related]

  • 37. Human T-cell lymphotropic virus type II in Guaraní Indians, Southern Brazil.
    Menna-Barreto M, Bender AL, Bonatto SL, Freitas LB, Salzano FM, Tsuneto LT, Petzl-Erler ML.
    Cad Saude Publica; 2005 May; 21(6):1947-51. PubMed ID: 16410882
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies.
    Qiu X, Hodges S, Lukaszewska T, Hino S, Arai H, Yamaguchi J, Swanson P, Schochetman G, Devare SG.
    J Med Virol; 2008 Mar; 80(3):484-93. PubMed ID: 18205214
    [Abstract] [Full Text] [Related]

  • 39. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA, Zucker-Franklin D, Marmor M, Legler PM.
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.